Home
/
Design Therapeutics, Inc.
/
Financials
/
Quarterly
Design Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Design Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 5, 2025
Q2
2025
Jun 30, 2025
$0
Aug 7, 2025
Q1
2025
Mar 31, 2025
$0
May 7, 2025
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2020
$20.0K
Nov 9, 2021
Q2
2021
Jun 30, 2020
$31.0K
Aug 9, 2021
Q1
2021
Mar 31, 2020
$142.0K
May 10, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($17.00M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($19.08M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($17.72M)
May 7, 2025
Q3
2025
Sep 30, 2024
($13.04M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($11.79M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($11.11M)
May 7, 2025
Q3
2024
Sep 30, 2023
($15.79M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($19.94M)
Aug 5, 2024
Q1
2024
Mar 31, 2023
($19.29M)
May 8, 2024
Q3
2023
Sep 30, 2022
($17.70M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($15.00M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($13.27M)
May 9, 2023
Q3
2022
Sep 30, 2021
($11.32M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($7.64M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($5.51M)
May 9, 2022
Q3
2021
Sep 30, 2020
($2.32M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($1.44M)
Aug 9, 2021
Q1
2021
Mar 31, 2020
($663.0K)
May 10, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($19.31M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($21.57M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($20.42M)
May 7, 2025
Q3
2025
Sep 30, 2024
($16.25M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($15.04M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($14.40M)
May 7, 2025
Q3
2024
Sep 30, 2023
($18.82M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($22.60M)
Aug 5, 2024
Q1
2024
Mar 31, 2023
($21.65M)
May 8, 2024
Q3
2023
Sep 30, 2022
($19.19M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($15.64M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($13.37M)
May 9, 2023
Q3
2022
Sep 30, 2021
($11.34M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($7.69M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($5.68M)
May 9, 2022
Q3
2021
Sep 30, 2020
($2.38M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($1.46M)
Aug 9, 2021
Q1
2021
Mar 31, 2020
($623.0K)
May 10, 2021